Nurix Therapeutics Receives FDA Fast-Track Designation for NX-5948
Nurix Therapeutics has received fast-track designation from the FDA for its treatment, NX-5948, for certain types of lymphocytic cancer....
small lymphocytic lymphoma
Eli Lilly’s Jaypirca Receives FDA Approval for Leukemia Treatment
In a major breakthrough, the FDA has granted approval to Eli Lilly's Jaypirca for the treatment of adults with...
Eli Lilly’s Jaypirca Receives FDA Approval for Leukemia Treatment
In a major breakthrough, the FDA has granted approval to Eli Lilly's Jaypirca for the treatment of adults with...
Bristol Myers Receives FDA Priority Review for Expanded Breyanzi Label
Bristol Myers Squibb has received priority review from the FDA for its CAR-T cell therapy Breyanzi, which is seeking...